Cargando…
Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1
Hyperlipidemia is an important lipid disorder and a risk factor for health. Aspirin eugenol ester (AEE) is a novel synthetic compound which is made up of two chemical structural units from aspirin and eugenol. Therapeutic effect of AEE on hyperlipidemia has been confirmed in animal model. But the ac...
Autores principales: | Xiao-Rong, Lu, Ning, Ma, Xi-Wang, Liu, Shi-Hong, Li, Zhe, Qin, Li-Xia, Bai, Ya-Jun, Yang, Jian-Yong, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656224/ https://www.ncbi.nlm.nih.gov/pubmed/34899293 http://dx.doi.org/10.3389/fphar.2021.733789 |
Ejemplares similares
-
Untargeted lipidomics and metagenomics reveal the mechanism of aspirin eugenol ester relieving hyperlipidemia in ApoE−/− mice
por: Lu, Xiao-Rong, et al.
Publicado: (2022) -
Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia
por: Ma, Ning, et al.
Publicado: (2018) -
Investigation of the Uptake and Transport of Aspirin Eugenol Ester in the Caco-2 Cell Model
por: Tao, Qi, et al.
Publicado: (2022) -
Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia
por: Karam, Isam, et al.
Publicado: (2015) -
Aspirin eugenol ester ameliorates LPS-induced inflammatory responses in RAW264.7 cells and mice
por: Liu, Xu, et al.
Publicado: (2023)